Volltextsuche
Hinweis: Bitte geben Sie einen Suchbegriff ein, z.B. "BMW", um alle Analysen und News über BMW aufgelistet zu bekommen, die innerhalb der Site von AktienCheck vorhanden sind! Zusätzlich können Sie noch eine Zeitspanne auswählen.
Suchergebnisse: (3691534 Ergebnisse gefunden) Es.
| Datum | Thema | |
|---|---|---|
| 20.04.26 | Swvl Announces FY 2025 Results; Revenue Up 41% to $24.2 million; Net Income $1.3 million; NDR of 128%; GCC Revenue Up 122% | |
| Net income of $1.3M in FY 2025 versus net loss of $10.3M in FY 2024. [...] | ||
| 20.04.26 | Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors | |
| NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it has appointed Heather Thiltgen to the Company’s Board of Directors, effective April 20, 2026. Ms. Th. [...] | ||
| 20.04.26 | AlphaTON Capital Rebrands as Alpha Compute Corp. to Reflect Its Growing AI Compute Business | |
| AlphaTON Capital Rebrands as Alpha Compute Corp. to Reflect Its Growing AI Compute Business. [...] | ||
| 20.04.26 | Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region | |
| CAMBRIDGE, Mass. and HANGZHOU, China, April 20, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and TJ Biopharma (“TJ Bio”) today announced that the companies have entered into a definitive agreement under which Biogen has agreed to acquire TJ Bio’s exclusive rights to felzartamab in the Greater China Region. [...] | ||
| 20.04.26 | Erdene Provides Q1 2026 Bayan Khundii Gold Mine Update | |
| HALIFAX, Nova Scotia, April 20, 2026 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN; OTCQX: ERDCF) ("Erdene" or the "Company") is pleased to provide a Bayan Khundii Gold Mine (“BK”) production update for Q1 2026, operated by Erdene Mongol LLC (“EM”), the Company’s joint venture with Mongolian Mining Corporation (“MMC”). [...] | ||
| 20.04.26 | Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026 | |
| James Treat, MD, Professor of Clinical Pediatrics and Dermatology at the Children’s Hospital of Philadelphia to present clinical results on Wednesday, May 20, 2026, at 4:30 p.m. ET . [...] | ||
| 20.04.26 | BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting | |
| PHILADELPHIA and VANCOUVER, British Columbia, April 20, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announces that it is presenting positive data in three clinical posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting, taking place April 17–22 at the San Diego Convention Center in San Diego, California. [...] | ||
| 20.04.26 | Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026 | |
| TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 first quarter earnings conference call on Monday, May 11, 2026 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and wi. [...] | ||
| 20.04.26 | Transactions in connection with share buyback programme | |
| Company Announcement. [...] | ||
| 20.04.26 | Bavarian Nordic – Transactions in Connection with Share Buy-Back Program | |
| COPENHAGEN, Denmark, April 20, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on March 12, 2026, under which the Company will repurchase shares for an amount up to DKK 200 million in the period from March 12, 2026 to May 13, 2026. The program is executed in accordance with Regulation (EU) No. [...] |
